Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,106,855
-
Share change
-
+6,106,855
-
Total reported value
-
$94,657,000
-
Price per share
-
$15.50
-
Number of holders
-
49
-
Value change
-
+$94,657,000
-
Number of buys
-
49
Institutional Holders of INTERSECT ENT INC - COM (XENT) as of Q3 2014
As of 30 Sep 2014,
INTERSECT ENT INC - COM (XENT) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,106,855 shares.
The largest 10 holders included
Norwest Venture Partners XI, LP, WELLINGTON MANAGEMENT CO LLP, WELLS FARGO & COMPANY/MN, LORD, ABBETT & CO. LLC, Novo A/S, MILLENNIUM MANAGEMENT LLC, ROYCE & ASSOCIATES LLC, FEDERATED INVESTORS INC /PA/, Alyeska Investment Group, L.P., and WALL STREET ASSOCIATES.
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.